Eribulin as Treatment for Metastatic Breast Cancer
3 Views
administrator
07/03/23
Factors that affect selection between available therapies for metastatic triple-negative breast cancer and considerations for treating with eribulin mesylate based on supporting data.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
-
Category
Show more
Facebook Comments
No comments found